{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-22-000039","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.426990+00:00","generated_at":"2026-06-24T03:07:22.169120+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ICU Medical Q2 revenue $561M; GAAP net loss $7.5M, adj EPS $1.37; updates FY guidance","bullets":["Revenue $561.0M vs $321.7M YoY; GAAP net loss $(7.5M) vs income $28.4M.","Adjusted diluted EPS $1.37 vs $1.88 YoY; Adjusted EBITDA $84.7M vs $66.9M.","GAAP gross margin fell to 30% from 38% YoY.","Company updated FY 2022 guidance; specific figures not provided in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-22-000039","json":"https://secwatch.observer/filing/0000883984-22-000039.json","markdown":"https://secwatch.observer/filing/0000883984-22-000039.md","text":"https://secwatch.observer/filing/0000883984-22-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000039/0000883984-22-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000039/icui-20220808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:07:22.169120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}